Edecrin

Edecrin is a brand name of ethacrynic acid, approved by the FDA in the following formulation(s):

EDECRIN (ethacrynate sodium - injectable; injection)

• 
  Manufacturer: ATON
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): EQ 50MG BASE/VIAL ^[RLD]

EDECRIN (ethacrynic acid - tablet; oral)

• 
  Manufacturer: ATON
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 25MG ^[RLD]

Has a generic version of Edecrin been approved?

No. There is currently no therapeutically equivalent version of Edecrin available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Edecrin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Edecrin.

See also...

• Edecrin Consumer Information (Wolters Kluwer)
• Edecrin Consumer Information (Cerner Multum)
• Edecrin Advanced Consumer Information (Micromedex)
• Ethacrynate Sodium Consumer Information (Wolters Kluwer)
• Ethacrynic Acid Consumer Information (Wolters Kluwer)
• Ethacrynic acid Consumer Information (Cerner Multum)
• Ethacrynate sodium Intravenous Advanced Consumer Information (Micromedex)
• Ethacrynic acid Advanced Consumer Information (Micromedex)
• Ethacrynate Sodium AHFS DI Monographs (ASHP)
• Ethacrynic Acid AHFS DI Monographs (ASHP)